1-5 of 5
Helong Zhao
Close
Sort by
Journal Articles

LPA81: Discovery of an Exceptionally Potent Protac Degrading Native and Mutant BCR-ABL1 Oncoprotein in CML

Milad Rouhimoghadam, Hua Tang, Junzhuo Liao, Briana Bates, Daniela Uribe-Cano, Helong Zhao, Weiping Tang, Michael W. Deininger
Journal: Blood
Blood (2022) 140 (Supplement 1): 485–486.
https://doi.org/10.1182/blood-2022-158308
Published: 2022
Journal Articles

CSF3R and SETBP1 getting high on LSD1

Helong Zhao, Michael W. Deininger
Journal: Blood
Blood (2022) 140 (6): 529–530.
https://doi.org/10.1182/blood.2022016740
Published: 2022
Journal Articles

MS4A3 promotes differentiation in chronic myeloid leukemia by enhancing common β-chain cytokine receptor endocytosis

Helong Zhao, Anthony D. Pomicter, Anna M. Eiring, Anca Franzini, Jonathan Ahmann, Jae-Yeon Hwang, Anna Senina, Bret Helton, Siddharth Iyer, Dongqing Yan, Jamshid S. Khorashad, Matthew S. Zabriskie, Anupriya Agarwal, Hannah M. Redwine, Amber D. Bowler, Phillip M. Clair, Shannon K. McWeeney, Brian J. Druker, Jeffrey W. Tyner, Derek L. Stirewalt, Vivian G. Oehler, Sooryanarayana Varambally, Kristofer C. Berrett, Jeffery M. Vahrenkamp, Jason Gertz, Katherine E. Varley, Jerald P. Radich, Michael W. Deininger
Journal: Blood
Blood (2022) 139 (5): 761–778.
https://doi.org/10.1182/blood.2021011802
Published: 2022
Includes: Supplemental data
Journal Articles

MS4A3 Promotes Differentiation in Chronic Myeloid Leukemia By Enhancing Common β Chain Cytokine Receptor Endocytosis

Helong Zhao, Anthony D. Pomicter, Anna M. Eiring, Anca Franzini, Jonathan Ahmann, Jae-Yeon Hwang, Anna V. Senina, Bret Helton, Siddharth Iyer, Dongqing Yan, Jamshid Khorashad, Matthew S. Zabriskie, Anupriya Agarwal, Hannah M Redwine, Amber D. Bowler, Phillip M. Clair, Shannon K. McWeeney, Brian J. Druker, Jeffrey W. Tyner, Derek Stirewalt, Vivian G. Oehler, Sooryanarayana Varambally, Kristofer Berrett, Jeffrey Vahrenkamp, Jason Gertz, Katherine Varley, Jerald P. Radich, Michael W. Deininger
Journal: Blood
Blood (2021) 138 (Supplement 1): 59.
https://doi.org/10.1182/blood-2021-151559
Published: 2021
Journal Articles

Exploiting LY3009120 and Asciminib Combination to Target TKI-Resistant CML

Milad Rouhimoghadam, Anthony D. Pomicter, Alexandria Van Scoyk, Greg Poffenberger, Ivaylo Kirov, Lyubomir G. Nashev, Helong Zhao, Martin Martinov, Michael W. Deininger
Journal: Blood
Blood (2021) 138 (Supplement 1): 3600.
https://doi.org/10.1182/blood-2021-153353
Published: 2021